Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$6.6M
+30.7% from 2023
Prescriptions
50
$132,892.66 per claim
Patients
-
6 prescribers
Total spending, 2024
$6.6M
- per patient
Medicare prescription drug plans paid $6.6M for Xenpozyme in 2024, for 50 prescriptions and refills to - patients (up 30.7% from 2023). The average cost per claim was $132,892.66.
Florida had the highest Medicare cost for Xenpozyme in 2024: $2.5M for 15 claims, followed by New York ($1.9M).
Christopher B Griffith, medical genetics and genomics in Fort Myers, FL, had the highest Medicare cost for Xenpozyme in 2024: 13 claims costing $1.9M.
Xenpozyme is made by Sanofi (SNY), listed in the Medicare spending data as Sanofi-Aventis.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Christopher B Griffith Fort Myers, FL | Medical Genetics and Genomics | 13 | Under 11 | $1.9M |
| Mark Goldstein Staten Island, NY | Rheumatology | 11 | Under 11 | $1.5M |
| Elizabeth R Jalazo |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2023 | 3 | 30 | - | $5.1M |
| 2024 | 6 | 50 | - | $6.6M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims |
|---|
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Pediatric Medicine |
| 18 |
| Under 11 |
| $1.3M |
| Spending |
|---|
| Sanofi-Aventis SNY | 50 | $6.6M |